News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Leading India Manufacturer Heparinex LLC and U.S. Companies Biological E. Limited and Choncept, LLC Sign Option/License Agreements



3/11/2008 8:39:20 AM

AUSTIN, Texas & HYDERABAD, India--(BUSINESS WIRE)--Biotechnology companies Heparinex, L.L.C. and Choncept, L.L.C. announced today option and license agreements with Biological E., Limited (BE), a leading biopharmaceutical company based out of India. The agreement provides BE with an option for novel production technologies for both heparin- and chondroitin-related carbohydrate compounds. Heparinex and Choncept are funded and managed by life sciences venture firm Emergent Technologies, Inc., and both companies are headed by Chief Scientist Dr. Paul DeAngelis.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES